FDA approves new weight-loss drug Zepbound
Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk's Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections.
Top Videos

FDA approves new weight-loss drug Zepbound

Man shot execution style, killed, while on bike in South Philly

Family files lawsuits over horrific death of Chester County girl
